Results of laparoscopic pelvic lymphadenectomy in patients at high risk for nodal metastases from prostate cancer

Annals of Surgical Oncology

Volumn 5, Issue 2, 1998, Pages 173-180

  Kava, Bruce R ^a   Dalbagni, Guido ^a   Conlon, Kevin C ^a   Russo, Paul ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Laparoscopic pelvic lymphadenectomy; Nodal metastases; Prostate cancer

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC VALUE; HISTOPATHOLOGY; HUMAN; LAPAROSCOPIC SURGERY; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; MALE; PELVIS LYMPH NODE; PROSTATE CANCER;

ACID PHOSPHATASE; BIOPSY; BLOOD LOSS, SURGICAL; BONE AND BONES; EVALUATION STUDIES; FOLLOW-UP STUDIES; FORECASTING; HOSPITALIZATION; HUMANS; INTRAOPERATIVE COMPLICATIONS; LAPAROSCOPY; LENGTH OF STAY; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PELVIS; PHYSICAL EXAMINATION; POSTOPERATIVE COMPLICATIONS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK FACTORS; SAFETY; SEMINAL VESICLES; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL;

EID: 0032417822     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02303851     Document Type: Article

References (62)

1. Utz DC. Radical excision of adenocarcinoma of the prostate with pelvic lymph node involvement: surgical gesture or curative procedure? Urology 1984;24(suppl 5):4-11.
2. Kramer SA, Cline WA Jr., Farnham R, Carson CC, Cox EB, Hishaw W, Paulson DF. Prognosis of patients with stage D1 prostatic adenocarcinoma. J Urol 1981;125:817-9.
3. Zincke H. Extended experience with surgical treatment of stage D1 adenocarcinoma of the prostate. Urology 1989;33(suppl 5):27-36.
4. Golimbu M, Provet J, Al- Askari S, Morales P. Radical prostatectomy for stage D1 prostate cancer: prognostic variable and result of treatment. Urology 1987;30.427-35.
5. Catalona WJ, Miller DR, Kavoussi LR. Intermediate-term survival results in clinically understaged prostate cancer patients following radical prostatectomy. J Urol 1988;140. 540-3.
6. Steinberg GD, Epstein JI, Piantadosi S, Walsh PC. Management of stage D1 adenocarcinoma of the prostate: the Johns Hopkins experience 1974-1987. J Urol 1990;144:1425-32.
7. Gervasi LA, Mata J, Easley JD, Wilbanks JH, Seale-Hawkins C, Carlton E Jr., Scardino PT. Prognostic significance of lymph node metastases in prostate cancer. J Urol 1989;142:332-6.
8. Leibel SA, Fuks Z, Zelefsky MJ, Whitmore WF. The effects of local and regional treatment on the metastatic outcome in prostatic carcinoma with pelvic lymph node involvement. Int J Radiat Oncol Biol Phys 1994;28:1:7-16.
9. Schmidt JD, Gibbons RP, Murphy GP, Bartolucci A. Adjuvant therapy for localized prostate cancer. Cancer 1993;71(suppl 3):1005-13.
10. Smith JA, Middleton RG. Implications of volume of nodal metastasis in patients with adenocarcinoma of the prostate. J Urol 1985; 133:617-9.
11. Anscher MS, Prosnitz MS. Prognostic significance of extent of nodal involvement in stage D1 prostate cancer treated with radiotherapy. Urology 1992;39:39-43.
12. Walsh JW, Amendola MA, Konerding KR, Tisnado J, Hazra TA. Computed tomographic detection of pelvic and inguinal lymphnode metastases from primary and recurrent pelvic malignant disease. Radiology 1980;137:157-66.
13. Emory TH, Reinke DB, Hill AL, Lange PH. Use of CT to reduce understaging in prostatic cancer: comparison with conventional staging techniques. AJR 1983;141:351-4.
14. Hricak H, Dooms GC, Jeffrey RB, et al. Prostatic carcinoma: staging by clinical assessment, CT, and MR imaging. Radiology 1987; 162:331-6.
15. Mukamel E, Hannah J, Barbaric Z, deKernion JB. The value of computerized tomography scan and magnetic resonance imaging in staging prostatic carcinoma: comparison with the clinical and histological staging. J Urol 1986;136:1231-3.
16. van Poppel H, Ameye F, Oyen R, van de Voorde W, Baert L. Accuracy of combined computerized tomography and fine needle aspiration cytology in lymph node staging of localized prostatic carcinoma. J Urol 1994;151:1310-4.
17. Brendler CB, Cleeve LK, Anderson EE, Paulson DF. Staging pelvic lymphadenectomy for carcinoma of the prostate: risk versus benefit. J Urol 1980;124:849-50.
18. McDowell GC II, Johnson JW, Tenney DM, Johnson DE. Pelvic lymphadenectomy for staging clinically localized prostate cancer. Urology 1990;35:476-82.
19. Paul DB, Loening SA, Narayan AS, Culp DA. Morbidity from pelvic lymphadenectomy in staging carcinoma of the prostate. J Urol 1983;129:1141-4.
20. Griffith DP, Schuessler WW, Nickell KG, Meaney JT. Laparoscopic pelvic lymphadenectomy for prostatic adenocarcinoma. Urol Clin North Am 1992;19:407-15.
21. Kerbl K, Clayman RV, Petros JA, Chandhoke PS, Gill IS. Staging pelvic lymphadenectomy for prostate cancer: a comparison of laparoscopic and open techniques. J Urol 1993;150:396-9.
22. Schuessler WW, Vancaillie TG, Reich H, Griffith DP. Transperitoneal endosurgical lymphadenectomy in patients with localized prostate cancer. J Urol 1991;145:988-91.
23. Parra RO, Andrus C, Boullier J. Staging laparoscopic pelvic lymph node dissection: comparison of results with open pelvic lymphadenectomy. J Urol 1992;147:875-8.
24. Doublet JD, Gattegno B, Thibault P. Laparoscopic pelvic lymph node dissection for staging of prostatic cancer. Eur Urol 1994;25: 194-8.
25. Rusktalis DB, Gerber GG, Vogelzang NJ, Haraf DJ, Straus FH II, Chodak GW. Laparoscopic pelvic lymph node dissection: a review of 103 consecutive cases. J Urol 1994;151:670-4.
26. Parra RO, Hagood PG, Boullier JA, Cummings JM, Mehan DJ. Complications of laparoscopic urological surgery: experience at St. Louis University. J Urol 1994;151:681-4.
27. Gill IS, Clayman RV. Laparoscopic pelvic lymphadenectomy. Surg Oncol Clin North Am 1994;3:323-36.
28. St. Lezin M, Cherrie R, Cattolica EV. Comparison of laparoscopic and minilaparotomy pelvic lymphadenectomy for prostate cancer staging in a community practice. Urology 1997;49:60-4.
29. Gleason DF. Classification of prostatic carcinomas. Cancer Chemother Rep 1966;50:125-8.
30. Gleason DF, Mellinger GT, Veterans Administration Cooperative Urological Research Group. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 1974;111:58-64.
31. Winfield HN, Schuessler WW. Pelvic lymphadenectomy: limited and extended. In: Clayman RV, McDougall EM, eds. Urological laparoscopy. St Louis: Quality Publishing, 1992:225-60.
32. See WA, Cohen MB, Winfield HN. Inverted V peritoneotomy significantly improves nodal yield in laparoscopic pelvic lymphadenectomy. J Urol 1993;149:772-5.
33. Hanks GE. Long term control of prostate cancer with radiation: past, present, and future. Urol Clin North Am 1996;23:605-16.
34. Miller JI, Ahmen FR, Drach GW, Emerson SS, Bottaccini MR. The clinical usefulness of serum prostate specific antigen after hormonal therapy of metastatic prostate cancer. J Urol 1992;147: 956-61.
35. Pilepich MV, Krall JM, Al-Sarraf M, et al. Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group. Urology 1995;45: 616-21.
36. Cheng CWS, Bergstralh EJ, Zincke H. Stage D1 prostate cancer: a nonrandomized comparison of conservative treatment options versus radical prostatectomy. Cancer 1993;71(suppl3):996-1004.
37. Whittington R, Malkowicz SB, Barbes MM, Broderick GA, van Arsdalen K, Dougherty MJ, Wein AJ. Combined hormonal and radiation therapy for lymph node- positive prostate cancer. Urology 1995;46:213-9.
38. Leibel SA, Zelefsky MJ, Kutcher GJ, Burman CM, Kelson S, Fuks Z. Three-dimensional conformal radiation therapy in localized carcinoma of the prostate: interim report of a phase I dose-escalation study. J Urol 1994;152:1792-8.
39. Golimbu M, Morales P, Al-Askari S, Brown J. Extended pelvic lymphadenectomy for prostatic cancer. J Urol 1979;121:617-20.
40. Lieskovsky G, Skinner DG, Weisenburger T. Pelvic lymphadenectomy in the management of carcinoma of the prostate. J Urol 1980;124:635-8.
41. Freiha FS, Pistenma DA, Bagshaw MA. Pelvic lymphadenectomy for staging prostatic carcinoma: is it always necessary? J Urol 1979;122:176-7.
42. Paulson DF. Management of prostatic malignancy. In: deKernion JB, Paulson DF, eds. Genitourinary Cancer Management. Philadelphia: Lea & Febiger, 1987:107-60.
43. vonEschenbach AC. Monograph on Carcinoma of the Prostate. AUA Update series VII, #4. Houston, TX: American Urological Association Office of Education, 1985.
44. Petros JA, Catalona WJ. Lower incidence of unsuspected lymph node metastases in 521 consecutive patients with clinically localized prostate cancer. J Urol 1992;147:1574-5.
45. Danella JF, deKernion JB, Smith RB, Steckel J. The contemporary incidence of lymph node metastases in prostate cancer: implications for laparoscopic lymph node dissection. J Urol 1993;149: 1488-91.
46. Wolf JS, Shinohara K, Kerlikowske KM, Narayan P, Stoller ML, Carroll PR. Selection of patients for laparoscopic pelvic lymphadenectomy prior to radical prostatectomy: a decision analysis. Urology 1993;42:680-8.
47. Kleer E, Larson-Keller JJ, Zincke H, Oesterling JE. Ability of preoperative serum prostate- specific antigen value to predict pathologic stage and DNA ploidy. Urology 1993;41:207-16.
48. Partin AW, Yoo J, Carter HB, Pearson JD, Chan DW, Epstein JI, Walsh PC. The use of prostate specific antigen, clinical stage, and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol 1993;150:110-4.
49. Sands ME, Zagars GK, Pollack A, von Eschenbach AC. Serum prostate-specific antigen, clinical stage, pathologic grade, and the incidence of nodal metastases in prostate cancer. Urology 1994; 44:215-20.
50. Bluestein DL, Bostwick DG, Bergstralh EJ, Oesterling JE. Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer. J Urol 1994;151:1315-20.
51. Berner A, Waere H, Nesland JM, Paus E, Danielsen HE, Fossa SD. DNA ploidy, serum prostate specific antigen, hisological grade and immunohistochemistry as predictive parameters of lymph node metastases in T1-T3/M0 prostatic adenocarcinoma. Br J Urol 1995;75:26-32.
52. Roach M III, Marquez C, Yuo H-S, et al. Predicting the risk of lymph node involvement using pretreatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 1993;28:33-7.
53. Greskovitch FJ III, Johnson DE, Tenney DM, Stephenson RA. Prostate specific antigen in patients with clinical stage C prostate cancer: relation to lymph node status and grade. J Urol 1991;145: 798-801.
54. Kramer SA, Cline WA Jr, Farnham R, Carson CC, Cox EB, Hinshaw W, Paulson DF. Prognosis of patients with stage D1 prostatic carcinoma. J Urol 1981;125:817-9.
55. Paulson DF, Pischerchia PV, Gardner W. Predictors of lymphatic spread in prostatic adenocarcinoma: uro-oncology research group study. J Urol 1980;123:697-9.
56. Sagalowsky AI, Milam H, Reveley LR, Silva FG. Prediction of lymphatic metastases by Gleason histologic grading in prostatic cancer. J Urol 1982;128:951-2.
57. McLaughlin AP, Saltzstein SL, McCullough DL, Gittes RF. Prostatic carcinoma: incidence and location of unsuspected lymphatic metastases. J Urol 1976;115:89-94.
58. Parra RO, Andrus CH, Boullier JA. Staging laparoscopic pelvic lymph node dissection: experience and indications. Arch Surg 1992;127:1294-7.
59. Fowler J, Whitmore W. The incidence and extent of pelvic lymph node metastases in apparently localized prostate cancer. Cancer 1981;47:2941-5.
60. Harrison SH, Seale-Hawkins C, Schum CW, Dunn JK, Scardino PT. Correlation between the side of palpable tumor and the side of pelvic lymph node metastasis in clinically localized prostate cancer. Cancer 1992;69:750-4.
61. Gerber GS, Bales GT, Gornik HL, Haraf DJ, Chodak GW, Rusktalis DB. Treatment of prostate cancer using external beam radiotherapy after laparoscopic pelvic lymph node dissection. Br J Urol 1996;77:870-5.
62. Guazzoni G, Montorsi F, Bergamaschi F, Bellinzoni P, Centemero A, Consonni P, Rigatti P. Open surgical revision of laparoscopic pelvic lymphadenectomy for staging of prostate cancer: the impact of laparoscopic learning curve. J Urol 1994;151:930-3.